The Center for Infectious Disease Research and Policy (CIDRAP), based at the  University of Minnesota, reported that the Centers for Disease Control (CDC) issued a warning on more tainted drugs. According to CIDRAP, “further testing on three more products from the New England Compounding Center (NECC) has turned up extensive contamination in three more products, and federal officials are asking healthcare workers to be alert for more infections, though they stopped short of calling the situation an outbreak.”

In a Health Alert Network (HAN) update, the CDC reported that, “some of the organisms found in unopened vials of NECC’s betamethasone, cardioplegia, and triamcinolone solutions can cause disease in humans.” Cardioplegia is a solution used to stop the heart during cardiac surgery. Betamethasone and triamcinolone are both steroids. All three products are subject to recall as part of the wider recall of all NECC products following the contamination of the company’s methylprednisolone acetate injections. The CDC reported that as of December 4, 541 fungal infections and 36 deaths have been linked to a multistate outbreak caused by contaminated methylprednisolone acetate injections from NECC.